Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3486297018 | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3494543018 | Product containing glycopyrronium bromide in parenteral dosage form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3494544012 | Product containing glycopyrrolate in parenteral dosage form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3494545013 | Glycopyrrolate in parenteral dosage form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3494546014 | Glycopyrronium bromide in parenteral dosage form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | est un(e) (attribut) | Product containing glycopyrronium bromide (medicinal product) | false | Inferred relationship | Some | ||
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | a pour principe actif (attribut) | Glycopyrrolate | false | Inferred relationship | Some | ||
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | false | Inferred relationship | Some | ||
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Glycopyrrolate 200micrograms/1mL injection | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 600micrograms/3mL injection | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection (product) | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection solution 1mL vial (product) | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection solution 5mL vial (product) | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection solution 20mL vial (product) | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection solution 2mL vial (product) | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Neostigmine+glycopyrronium (product) | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Neostigmine 2.5mg/glycopyrronium 500mcg injection solution 1mL ampule (product) | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection ampule | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 200 microgram/mL solution for injection ampule | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 600 microgram/3 mL solution for injection ampule | est un(e) (attribut) | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
FHIR